RIGImmune is a biopharmaceutical company that is developing a new class of immune-modulating therapies for RNA virus diseases and antitumor immune response induction.

Biotechnology

Pharmaceutical

RIGImmune

The Farmington office likely focuses on strategic oversight and scientific guidance in a collaborative environment.

Farmington

Radhakrishnan Iyer

Nilesh Wadhwa

Garth Rapeport

Monica Zhou

Jesal Shah

Martin Driscoll

Anna Marie Pyle

Nihal Sinha

Kazuhiro Ito

Akiko Iwasaki

This department focuses on guiding organizational strategy and overseeing key initiatives.

Leadership Group

This department is responsible for providing strategic direction and governance for the organization.

Executive Leadership

This department oversees the management and strategy of investment portfolios.

Investment Management

The Scientific and Technical Advisory team at RIGImmune provides expert guidance on the strategic direction of the company's research and development efforts, ensuring scientific rigor and technical feasibility. This includes advising on the development of innovative immune-modulating therapies, evaluating emerging technologies, and fostering collaborations to advance treatments for RNA virus diseases and antitumor immune responses.

Scientific and Technical Advisory

The Leadership Team at RIGImmune, comprising the President, Chief Development Officer, and Chief Technical Officer, is responsible for setting the strategic direction, overseeing development initiatives, and guiding technical innovation to advance the company's immune-modulating therapies for RNA virus diseases and antitumor responses.

RIGImmune

Org chart

Board & advisors

Teams

Leadership Group

Executive Leadership

Investment Management

Scientific and Technical Advisory

Leadership Team

Offices

RIGImmune

Org chart

Board & advisors

Teams

Leadership Group

Executive Leadership

Investment Management

Scientific and Technical Advisory

Leadership Team

Offices

Related companies